Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer

Completed

• Conditions: Cervical Cancer Screening

• Registration Number: NCT01287871
• Lead Sponsor: City of Hope Medical Center

Brief Summary

This study aims to 1) implement a culturally and contextually rooted innovative multifoci, social marketing intervention involving societal focused media campaign elements to break down the barriers and facilitate timely and appropriate screening practices for cervical cancer; 2) measure cervical cancer stigma from a culturally relevant theoretical and conceptual framework; and 3) assess the influence of stigma on hindering seeking the PAP test. Further, this is an international study that will bring together a multi-disciplinary investigatory team, community advocates and State health agencies to deliver a social marketing intervention in Southern California (the Inland Empire region specifically) and Trinidad and Tobago.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-01
• Study First Submitted: 2011-01-31
• Study First Submitted QC: 2011-01-31
• Study First Posted: 2011-02-02
• Status Verified: 2012-10
• Primary Completion: 2012-10
• Study Completion: 2012-10
• Last Update Submitted: 2012-10-12
• Last Update Posted: 2012-10-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 332

Inclusion Criteria

Women will be included if they:

1. have not been diagnosed with any type of cancer
2. are between the ages of 18-70
3. self-identify as being African descended or Latina
4. are able to speak English and/or Spanish
5. acknowledge that a Pap test is currently needed

Exclusion Criteria

1. Cervical cancer is diagnosed only in women, therefore this study only includes women
2. Women who have been and/or are currently diagnosed with any type of cancer will be excluded
3. Women with other major medical conditions (e.g. stroke and degenerative illness) will be excluded
4. During the screening the level of symptomatology for depression and anxiety will be assessed. Women with severe depression and anxiety will be excluded, but appropriate psychological follow-up and referral will be provided
5. Women older than 70 years will be excluded

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of the ability of the social media intervention "End Stigma End Fear, End Cervical Cancer" to counter stigma of cervical cancer among disadvantaged women who acknowledge needing a Pap test at pre-intervention baseline	3 months after the intervention is implemented	To evaluate the ability of the social media intervention "End Stigma End Fear, End Cervical Cancer" to counter stigma of cervical cancer, by determining whether, among disadvantaged women who acknowledge needing a Pap test at pre-intervention baseline, degree of exposure to the intervention is associated with the following endpoints at 3 months after the intervention is implemented: 1. post-intervention change in stigma score relative to pre-intervention, and; 2. Pap testing (scored as 0=made no attempt, 1=made some attempt but did not get tested, 2=obtained Pap test).

Secondary Outcome Measures

Name	Time	Method
Assessment of whether change in stigma score is associated with Pap testing.	3 months after the intervention is implemented
Identification of factors associated with exposure to the intervention overall and to its individual components	3 months after the intervention is implemented
Assessment of whether each component of the intervention is associated with the study endpoints, by testing the 4 components (billboards/posters, newspaper advertisements, health brochures, and radio announcements) rather than the overall exposure score	3 months after the intervention is implemented

Trial Locations

Locations (1)

City of Hope Medical Center; 🇺🇸 Duarte, California, United States